David E. Clarke

Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor.

Douglas A. Craig, David E. Clarke · Journal of Pharmacology and Experimental Therapeutics · 1990 · 263 citations

Pharmacological pleiotropism of the human recombinant <i>α</i>_1A‐adrenoceptor: implications for <i>α</i>₁‐adrenoceptor classification

Anthony Ford, Donald V. Daniels, David J. Chang et al. · British Journal of Pharmacology · 1997 · 219 citations · Full text

Molecular Pharmacology, Urology, Molecular Physiology +14

5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae

Gordon S. Baxter, Douglas A. Craig, David E. Clarke · Naunyn-Schmiedeberg s Archives of Pharmacology · 1991 · 203 citations

Medicine, Physiology, Neurotransmitter +7

RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.

Anthony Ford, Nicolas F. Arredondo, David R. Blue et al. · Molecular Pharmacology · 1996 · 193 citations

Self-Healing, Self-Assembled β-Sheet Peptide–Poly(γ-glutamic acid) Hybrid Hydrogels

David E. Clarke, E. Thomas Pashuck, Sérgio Bertazzo et al. · Journal of the American Chemical Society · 2017 · 169 citations · Full text